Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Baxter
US Army
Argus Health
Boehringer Ingelheim
Cerilliant
Deloitte
Julphar
Farmers Insurance
Fish and Richardson

Generated: October 21, 2017

DrugPatentWatch Database Preview

SYNTHROID Drug Profile

« Back to Dashboard

What is the patent landscape for Synthroid, and when can generic versions of Synthroid launch?

Synthroid is a drug marketed by Abbvie and is included in one NDA.

The generic ingredient in SYNTHROID is levothyroxine sodium. There are ten drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the levothyroxine sodium profile page.

Summary for Tradename: SYNTHROID

US Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list7
Bulk Api Vendors: see list57
Clinical Trials: see list12
Patent Applications: see list6,591
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:SYNTHROID at DailyMed

Pharmacology for Tradename: SYNTHROID

Ingredient-typeThyroxine
Drug Classl-Thyroxine
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbvie
SYNTHROID
levothyroxine sodium
TABLET;ORAL021402-001Jul 24, 2002AB1,AB2RXYesNo► Subscribe► Subscribe► Subscribe
Abbvie
SYNTHROID
levothyroxine sodium
TABLET;ORAL021402-007Jul 24, 2002AB1,AB2RXYesNo► Subscribe► Subscribe► Subscribe
Abbvie
SYNTHROID
levothyroxine sodium
TABLET;ORAL021402-004Jul 24, 2002AB1,AB2RXYesNo► Subscribe► Subscribe► Subscribe
Abbvie
SYNTHROID
levothyroxine sodium
TABLET;ORAL021402-011Jul 24, 2002AB1,AB2RXYesYes► Subscribe► Subscribe► Subscribe
Abbvie
SYNTHROID
levothyroxine sodium
TABLET;ORAL021402-008Jul 24, 2002AB1,AB2RXYesNo► Subscribe► Subscribe► Subscribe
Abbvie
SYNTHROID
levothyroxine sodium
TABLET;ORAL021402-002Jul 24, 2002AB1,AB2RXYesNo► Subscribe► Subscribe► Subscribe
Abbvie
SYNTHROID
levothyroxine sodium
TABLET;ORAL021402-003Jul 24, 2002AB1,AB2RXYesNo► Subscribe► Subscribe► Subscribe
Abbvie
SYNTHROID
levothyroxine sodium
TABLET;ORAL021402-006Jul 24, 2002AB1,AB2RXYesNo► Subscribe► Subscribe► Subscribe
Abbvie
SYNTHROID
levothyroxine sodium
TABLET;ORAL021402-005Jul 24, 2002AB1,AB2RXYesNo► Subscribe► Subscribe► Subscribe
Abbvie
SYNTHROID
levothyroxine sodium
TABLET;ORAL021402-010Jul 24, 2002AB1,AB2RXYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Daiichi Sankyo
Baxter
Johnson and Johnson
Mallinckrodt
Moodys
Harvard Business School
Fish and Richardson
Cerilliant
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot